RECRUITING

Assessing Claims of Cannabis as an Anti-cancer Agent (CATA)

Description

The purpose of the study is to find out how cannabis may help control cancer growth by reviewing medical records of patients who report cannabis helped treat their cancer.

Conditions

CancerCancer (With or Without Metastasis)
Talk to us

Related Conditions:

CancerCancer (With or Without Metastasis)

Study Overview

On this page

Study Details

Study overview

The purpose of the study is to find out how cannabis may help control cancer growth by reviewing medical records of patients who report cannabis helped treat their cancer.

Cannabis as an Anti-cancer Agent: A Review of Medical Records in Patients With Cancer to Assess Potential Anti-cancer Benefits From Using Cannabis

Assessing Claims of Cannabis as an Anti-cancer Agent (CATA)

Condition
Cancer
Intervention / Treatment

-

Contacts and Locations

Saint Louis Park

HealthPartners Institute Cancer Research Center, Saint Louis Park, Minnesota, United States, 55426

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * diagnosed with cancer
  • * have used any type of cannabis/marijuana, including those with cannabidiol (CBD) and/or tetrahydrocannabinol (THC) to treat their cancer
  • * believe that cannabis has either stopped the tumor from growing and/or caused a cancer antigen blood marker to remain stable or cannabis has shrunken the tumor and/or caused reduction in a cancer antigen blood marker
  • * does not have cancer
  • * has not used any type of cannabis/marijuana, including those with CBD and/or THC to treat their cancer
  • * does not believe that cannabis has either stopped the tumor from growing and/or caused a cancer antigen blood marker to remain stable or cannabis has shrunken the tumor and/or caused reduction in a cancer antigen blood marker

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

HealthPartners Institute,

Study Record Dates

2027-01